NCT04618094

Prehabilitation in Patients Suffering From Gynecological Cancers

Status unknown NA Last updated 5 November 2020

What this trial tests

NA trial testing bicycle ergometer training with different intensities in Prehabilitation in 45 participants. Status unknown.

Timeline

1 January 2021

Primary endpoint
1 January 2022

1 January 2023

Quick facts

Lead sponsor	Medical University of Vienna
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	supportive care
Enrollment	45
Start date	1 January 2021
Primary completion	1 January 2022
Estimated completion	1 January 2023

Drugs / interventions tested

• bicycle ergometer training with different intensities

Conditions studied

• Prehabilitation — all drugs for Prehabilitation →

Sponsor

Medical University of Vienna

Who can join

Adults 18 to 80, female only, with Prehabilitation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In 2016, 2216 Austrian women (= 10% of all new cancer cases) were diagnosed with gynecological tumors. Depending on stage and entity, a main primary therapy option is the surgical tumor resection. In the phase of Prehabilitation (= the time frame from diagnosis to surgical intervention) supportive therapy options such as individualized exercise interventions potentially improve recovery and postoperative outcomes after surgical interventions. The primary aim of this study is to investigate the feasibility and acceptance of a prehabilitation training intervention with high-intensity interval training compared to a conventional moderate intensity continuous training and a non-training collective. Secondary goals are the investigation of the effectiveness of threshold-based intensity prescriptions and the impact on quality of life, fatigue, anxiety, depression, sexuality and ability to work.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.